Researchers discover enzyme inhibitors to stop replication of SARS-CoV-2, forging a path for potential new antiviral drugs
Q&A with Rudy Richardson
Researchers from the University of Michigan School of Public Health studied two viral enzymes, Mpro and PLpro, essential for the survival of SARS-CoV-2, as targets for potential new antiviral drugs to defend against COVID-19. Their work was recently published in Computers in Biology and Medicine.